upgrades - Turbo Option Trading

Upgrades

Ligand Moves to Strong Buy: Rationale Behind the Upgrade

May 14, 2024 author

Investors might want to bet on Ligand Pharmaceuticals (NASDAQ: LGND), as it has been recently upgraded to a Zacks Rank #1 (Strong Buy). This rating change essentially reflects an upward trend in earnings estimates — one of the most powerful forces impacting stock prices. A company’s changing earnings picture is at the core of the […]

Upgrades

All You Need to Know About Henkel AG & Co. Rating Upgrade to Buy

May 13, 2024 author

Henkel AG & Co. (OTC: HENKY) could be a solid addition to your portfolio given its recent upgrade to a Zacks Rank #2 (Buy). This upgrade is essentially a reflection of an upward trend in earnings estimates — one of the most powerful forces impacting stock prices. The sole determinant of the Zacks rating is […]

Upgrades

Virtu Financial Upgraded to Strong Buy: Here’s What You Should Know

May 13, 2024 author

Virtu Financial (NASDAQ: VIRT) could be a solid addition to your portfolio given its recent upgrade to a Zacks Rank #1 (Strong Buy). This upgrade is essentially a reflection of an upward trend in earnings estimates — one of the most powerful forces impacting stock prices. The sole determinant of the Zacks rating is a […]

Upgrades

All You Need to Know About Crescent Capital BDC Rating Upgrade to Buy

May 13, 2024 author

Crescent Capital BDC (NASDAQ: CCAP) appears an attractive pick, as it has been recently upgraded to a Zacks Rank #2 (Buy). This rating change essentially reflects an upward trend in earnings estimates — one of the most powerful forces impacting stock prices. A company’s changing earnings picture is at the core of the Zacks rating. […]

Upgrades

What Makes Cartesian Therapeutics, Inc. a New Buy Stock

May 13, 2024 author

Cartesian Therapeutics, Inc. (NASDAQ: RNAC) could be a solid addition to your portfolio given its recent upgrade to a Zacks Rank #2 (Buy). This rating change essentially reflects an upward trend in earnings estimates — one of the most powerful forces impacting stock prices. The sole determinant of the Zacks rating is a company’s changing […]

Upgrades

Bullish On Bumble: Analyst Predicts Growth From New Features

May 10, 2024 author

Amid struggles in a highly saturated market and earnings misses, Bumble Inc. (NASDAQ:BMBL) has seen a steep drop in share price since its 2021 initial public offering. However, an analyst has raised the company’s rating after seeing encouraging signs that surpass Wall Street forecasts. The Bumble Analyst: Bank of America analyst Curtis Nagle upgraded Bumble […]

Upgrades

Why Is Coffee Chain Dutch Bros Stock Gaining Today?

May 10, 2024 author

Shares of Dutch Bros Inc (NYSE:BROS) shares are trading higher after TD Cowen analyst Andrew Charles upgraded the stock from Hold to Buy and raised the price target from $33 to $46. On Tuesday, Dutch Bros reported quarterly earnings of 9 cents per share which beat the analyst consensus estimate of 2 cents by 350%. Quarterly sales clocked in at $275.1 million, beating […]

Upgrades

Squarespace To See Whopping 20% Growth Over Medium Term On Pricing Tailwinds: Analyst

May 10, 2024 author

Mizuho analyst Siti Panigrahi upgraded Squarespace (NYSE:SQSP) to Buy from Neutral, raising the forecast to $50 from $34. According to the analyst, the company can deliver a significant upside to consensus estimates. The upside scenario implies almost 22% year-over-year growth in 2024 (consensus at 19%). Squarespace also has potential for 20% year-over-year growth in 2025 (consensus at 14%). The major growth levers […]

Upgrades

Analysts’ Varied Perspectives On CytomX’s CX-904 Cancer Study: Safety Profile But Caution in Pancreatic Cancer

May 9, 2024 author

Wednesday, CytomX Therapeutics Inc (NASDAQ:CTMX) released initial data from the ongoing CX-904 Phase 1a dose escalation clinical study, demonstrating a favorable safety profile and confirmed anti-cancer activity. As of April 16, 2024, data cutoff, the Phase 1 study enrolled 35 heavily pretreated patients with advanced metastatic solid tumor types. CX-904 demonstrated a favorable safety profile, supporting administration and […]

Upgrades

SiTime Stock Skyrockets 30% After Analyst Upgrade

May 9, 2024 author

SiTime Corp (NASDAQ:SITM) shares are trading higher after Needham analyst Quinn Bolton upgraded the stock rating from Hold to Buy with a $130 price target. SiTime posted revenue of $33.0 million, down 13.9% year over year, but above Bolton’s estimate and the Street’s $32 million estimate, due to downward trends in customer inventories that resulted in a pickup in order activity. Only […]

Share this video